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Natural killer (NK) cells play a well-recognized role in
early pathogen containment and in shaping acquired
cell-mediated immunity. However, indirect evidence
in humans and experimental models has suggested
that NK cells also play negative regulatory roles dur-
ing chronic disease. To formally test this hypothesis,
we employed a well-defined experimental model of
visceral leishmaniasis. Our data demonstrated that
NKp46+CD49b+CD3 NK cells were recruited to the
spleen and into hepatic granulomas, where they in-
hibited host protective immunity in an interleukin-10
(IL-10)-dependent manner. Although IL-10 mRNA
could be detected in activated NK cells 24 hr after
infection, the inhibitory function of NK cells was
only acquired later during infection, coincident with
increased IL-10 mRNA stability and an enhanced
capacity to secrete IL-10 protein. Our data support
a growing body of literature that implicates NK cells
as negative regulators of cell-mediated immunity
and suggest that NK cells, like CD4+ T helper 1 cells,
may acquire immunoregulatory functions as a conse-
quence of extensive activation.
INTRODUCTION
Natural killer (NK) cells are known to provide a critical host de-
fense system during the early phases of infection with a variety
of viruses, fungi, bacteria, and parasites (Bancroft, 1993; Biron
et al., 1999; Cerwenka and Lanier, 2001; Farag et al., 2002;
Smyth et al., 2002; Trinchieri, 1989). NK cells do not possess
conventional clonotypic antigen-specific receptors but are
capable of spontaneously killing tumor cells and virus-infected
cells that have downregulated one or more major histocompati-
bility complex (MHC) molecules and/or expressed certain stress
antigens on their surface (Diefenbach and Raulet, 2003; Mehro-
tra et al., 1998). NK cells have also been shown to play an
important role during pregnancy (Moffett-King, 2002), auto-immunity, and tissue inflammation (Homann et al., 2002; Shi
et al., 2000).
Target recognition and cytokine stimulation are the two major
triggeringmechanisms for NK cells, and both shape their effector
responses (Alli and Khar, 2004; Chakir et al., 2001; Fehniger
et al., 1999; Lauwerys et al., 2000;Mehrotra et al., 1998). Consid-
erable advances have been made in understanding the recep-
tors that activate and inhibit functionally mature NK cells and in
the cytokines leading to IFN-g production and cytoloytic activity.
However, less is known about the regulation of other aspects of
NK cell differentiation. In vitro studies have suggested that NK
cells can also differentiate to produce interleukin-10 (IL-10)
(Bodas et al., 2006; Grant et al., 2008; Moretta et al., 2002) and
may have regulatory activity (Deniz et al., 2008). Although a neg-
ative regulatory role for NK cells mediated through IL-10 has
been suggested during tumor development, in pregnancy, and
most recently during persistent Hepatitis C virus infection (Bar-
ber et al., 2007; De Maria et al., 2007; Vigano et al., 2001), direct
experimental evidence for a negative regulatory role of NK cells
during infectious disease is lacking.
We have been investigating the underlying cellular events that
regulate the effectiveness of host protective immunity after infec-
tion with the protozoan parasite Leishmania donovani.
Resistance to this pathogen operates largely through the devel-
opment of granulomatous inflammation, positively regulated by
both T helper 1 (Th1) and Th2 cell cytokines (Stager et al.,
2003) and negatively regulated largely by IL-10 (Murray et al.,
2002). Although natural T regulatory (Treg) cells have received
much attention in models of cutaneous leishmaniasis caused
by L. major (Belkaid et al., 2002), in experimental visceral leish-
maniasis (VL) caused by L. donovani (Stager et al., 2006), chronic
cutaneous leishmaniasis caused by L. major Seidman (Anderson
et al., 2007), and also during human kala azar (Nylen et al., 2007),
the bulk of IL-10-producing CD4+ T cells are inducible Foxp3
and CD25 regulatory T cells . A large fraction of these IL-10+
CD4+ T cells also coexpress IFN-g, suggesting that they may,
as in chronic toxoplasmosis (Jankovic et al., 2007), represent
a further stage of Th1 cell differentiation (O’Garra and Vieira,
2007). We now show that after L. donovani infection, NK cells ac-
cumulate in the spleen and in hepatic granulomas of infected
mice and that these NK cells represent another source of IL-10
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Regulation of Host Immunity by NK Cellsduring infection. Using adoptive transfer, we also provide formal
evidence that NK cells from infected mice suppressed host re-
sistance in an IL-10-dependent manner. Although upregulation
of IL-10 gene expression was also found to be a feature of early
NK cell activation, only NK cells isolated from mice with estab-
lished infection could suppress host resistance, a function asso-
ciated with the acquisition of increased IL-10 mRNA stability and
an enhancement of IL-10 protein secretion. Thus, our data sug-
gest a mechanism whereby prolonged in vivo activation gives
rise to a population of NK cells with altered posttranscriptional
regulation of IL-10 gene expression, heightened capacity for
IL-10 protein production, and inhibitory function.
RESULTS
NK Cells Accumulate IL-10 mRNA during the
Development of Experimental VL
IL-10 is a major contributor to disease progression in many dis-
eases (Murphy et al., 2001; Murray et al., 2002; Sharma et al.,
1999), and IL-10 production in experimental leishmaniasis has
been attributed to CD4+ T cells and macrophages (Anderson
et al., 2007; Miles et al., 2005; Stager et al., 2006). As part of
a more complete analysis of the IL-10 response to L. donovani
infection, we examined IL-10 mRNA accumulation in a variety
of highly enriched (>98% pure) cell populations in the absence
of in vitro restimulation. In accord with our recent description of
the late emergence of IL-10-producing CD25Foxp3 CD4+
T cells (Stager et al., 2006), the accumulation of IL-10 mRNA
within the splenic CD4+ T cell population increased over time.
However, wewere surprised to note thatCD49b+ (DX5+) NKcells,
and not CD4+ or CD8+ T cells, B cells, CD11chi cells, or macro-
phages, had accumulated most IL-10 mRNA by day 14 and
that their mRNA accumulation equaled that of CD4+ T cells at
day 28 after infection (p.i.; Figure 1A). Thus, within the splenic
populations examined here, NK cells represented a previously
unrecognized potential source of IL-10 during this infection.
NK Cells Expand in Number and Enter
Hepatic Granulomas
During L. donovani infection, the spleen undergoes extensive
architectural remodeling associated with splenomegaly, both
characteristics also associated with human disease (Kaye
et al., 2004). However, neither the number of NK cells nor their
distribution has previously been reported. The latter has been
problematic because of the lack of appropriate means to unam-
biguously identify NK cells in tissue sections in BALB/c mice.
NKp46 has recently been described as a marker for NK cells in
themouse (Walzer et al., 2007) and is suitable for in situ detection
of NK cells via immunohistochemistry. First, we confirmed ex-
pression of NKp46 on CD49b+ splenic NK cells in naive BALB/c
mice. As shown in Figure 1B (upper panel), more than 95% of
CD3CD49b+ cells stained brightly for NKp46. Using NKp46,
we therefore determined the distribution of NK cells in the spleen
of naive mice (Figure 1C). As suggested by previous studies
(Andrews et al., 2001; Dokun et al., 2001; Walzer et al., 2007),
NKp46+ cells were located predominantly within the marginal
zone and red pulp. As with CD49b+ cells found in naive mice,
almost all CD49b+ NK cells in L. donovani-infected mice
coexpressed NKp46 (Figure 1B, lower panel). In addition, of
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(compared to 97.4% ± 1.38% in naive mice; Figure S1 available
online). In infectedmice, a subset of CD49b+ cells also expressed
CD11c at low intensity, potentially allowing theirmisclassification
as immature conventional (cDCs) or plasmacytoid DCs (Blasius
et al., 2007; Caminschi et al., 2007; Vosshenrich et al., 2007).
However, the CD11cloCD49b+ cells observed in infected mice
were uniformly MHCII by flow cytometry, lacked intracellular
MHCII by immunocytochemistry, did not express the costimula-
tory markers CD80 and CD86, and did not express either Gr-1 or
B220 (Figures S2–S4 and data not shown). Staining with NKp46
therefore allowed us to unambiguously define NK cells in the
spleen of mice infected with L. donovani (Figure 1D). NK cells
were located within the red pulp and marginal zone, in a similar
distribution to that of NK cells in naive mice.
In the liver of infected mice, immunity to L. donovani is
expressed in granulomas (Engwerda and Kaye, 2000). To deter-
mine whether NK cells contributed to the cellular composition of
hepatic granulomas, we first confirmed NKp46 expression on
hepatic CD49b+CD3 cells in both naive and infected mice (Fig-
ure 1E). Next, we performed immunohistochemistry with NKp46.
The response of BALB/c mice has been well characterized
previously and at day 14–28 p.i., granulomas can be seen in
a variety of stages of maturation (Stager et al., 2003).
NKp46+CD3 cells were readily identified within immature and
mature granulomas and also within the parenchyma (Figures
1F–1H). By thin-section analysis,75% of all detectable hepatic
NK cells were within granulomas, and NK cells were observed in
60% of the granulomas examined. Given the relatively low fre-
quency of NK cells per granuloma, we cannot rule out the possi-
bility that all granulomas might contain NK cells if examined
across their entire volume.
To determine whether splenic and hepatic NK cells increased
in number during infection, we quantified NK cells by flow cytom-
etry. As shown in Figure 2A, inmice infectedwith L. donovani, the
absolute number of splenic NK cells increased by 3-fold. A sim-
ilar, though less pronounced, increase in hepatic NK cells was
also observed (Figure 2B). To confirm the kinetics of acquisition
of IL-10 mRNA by hepatic CD49b+NKp46+ NK cells in relation to
CD4+ and CD8+ T cells, we again performed qRT-PCR on flow-
sorted cells at different times after infection. As shown in Figures
2C and 2D, both splenic and hepatic NK cells with increased IL-
10 mRNA accumulation were readily detected by day 7 p.i. He-
patic CD4+ T cells with elevated levels of IL-10 mRNA appeared
more rapidly than in spleen, whereas the kinetics of the IL-10 re-
sponse in CD8+ T cells was similar in both organs. Together,
these data demonstrate that during the course of L. donovani in-
fection, NK cells are one of the first populations to increase their
potential for IL-10 production, that their numbers increase in in-
fected tissues, and that they can home specifically into both the
infected spleen and sites of granulomatous inflammation.
IL-10-Producing NK Cells Suppress Host
Resistance to L. donovani
Next, we wished to determine whether NK cells had the capacity
to regulate the outcome of infection, as might be suggested by
their increased accumulation of IL-10 mRNA. We first depleted
NK cells in vivo by using anti-ASGM1. Treatment of mice with
anti-ASGM1 has been commonly used to deplete NK cells,
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Regulation of Host Immunity by NK CellsFigure 1. Cellular Accumulation of IL-10 mRNA during L. donovani Infection
(A) Spleen cell were prepared from naive BALB/c mice and BALB/c mice infected for 14 days or 28 days with L. donovani. CD4+CD3+ and CD8+CD3+ T cells,
B220+ B cells, CD49b+ NK cells, CD11chi DCs, and all residual cells (including macrophages and stromal cells) were sorted to > 99% purity and then examined
for IL-10 mRNA accumulation by RT-PCR. Data represent mRNA samples from sorted cells isolated from pools of n = 5 spleens and are shown as n-fold differ-
ence over naive. One of three independent experiments is shown.
(B) Spleen cell suspensions from naive BALB/c mice (upper panel) and BALB/c mice infected for 28 days with L. donovani (lower panel) were stained for CD49b
and NKp46. Plots are gated on CD49b+CD3 cells.
(C andD) Immunohistology of (C) naive and (D) day 28-infected BALB/c spleen showing distribution of NKp46+NK cells (green) and F4/80+ red-pulpmacrophages
(red). Sections were counterstained with DAPI (blue).
(E) Hepatic NK cells coexpress CD49b and NKp46. Cells from naive (upper panel) and day 28-infected (lower panel) BALB/c mice were gated as CD49b+CD3.
For further characterization, see Figure S1.
(F) NKp46+ NK cells (green) colocalize with F4/80+ macrophages (blue) and CD3+ T cells (red) in hepatic granulomas caused by L. donovani.
(G andH) Frequency of granulomas identified as containing NKp46+ cells (G) and the frequency of NKp46+ cells located inside granulomas or outside granulomas,
i.e., in the parenchyma (H), was enumerated from approximately 35–40 granulomas per mouse (in 20 random 8 mmsections). Data represent mean ± SD obtained
from three mice.though this antibody has known reactivity against other cells as
well (Slifka et al., 2000). Antibodies were administered over the
first 6 days of infection (see Experimental Procedures) and led
to a rapid decrease in the frequency of CD49b+ cells (from
2.27% in control-treated mice to 0.04% in mice treated for 24
hr with anti-ASGM1), which was sustained over the first 7 days
p.i. Treatment with anti-ASGMI significantly reduced parasite
burden in the spleen (to 55% ± 8.5% of control; p < 0.001) and
liver (to 48%±9%of control; p < 0.001) of infectedmice, asmea-
sured at day 28 p.i. Whereas ASGM1 stained < 2% of CD4+ and
< 5% of CD8+ spleen cells in naive BALB/c mice, ASGM1 ex-
pression was markedly increased on T cells in infected mice(15% and 32% of CD4+ and CD8+ T cells, respectively, at
day 21 p.i.; data not shown), making this approach unsuitable
for analyzing the role of NK cells at later stages of infection. To
circumvent this problem, we used an adoptive-transfer ap-
proach to test whether NK cells could influence the outcome of
infection in otherwise unmanipulated hosts. Recipient BALB/c
mice were infected with L. donovani, and at day 21 p.i. they
were adoptively transferred with 106 NK cells derived from either
naive or day 21-infected mice. Parasite burden was then evalu-
ated 7 days later (day 28 p.i.). At this time, hepatic resistancewas
beginning to be expressed, whereas parasite numbers were in-
creasing in the spleen (Engwerda and Kaye, 2000). Transfer of
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had been previously infected for 21 days had no effect on splenic
(Figure 3A) or hepatic (Figure 3B) parasite burden. In contrast,
adoptive transfer of splenic NK cells from day 21-infected mice
into day 21-infected recipients significantly suppressed host
resistance in both organs. In four independent experiments
(n = 13–18 mice), NK cells from day 21-infected mice increased
parasite burden by 2.47 ± 0.17-fold and 1.86 ± 0.16-fold in
spleen and liver respectively (p < 0.001), whereas NK cells
from naive mice increased parasite burden by 1.1 ± 0.16-fold
and 1.25 ± 0.02-fold in spleen and liver, respectively (p = ns).
These data indicated that NK cells from infected but not naive
mice could inhibit host resistance to L. donovani. To confirm
the fate of the adoptively transferred NK cells, we CFSE labeled
NK cells from naive and infectedmice prior to transfer, in order to
allow visualization by immunohistochemistry and flow cytome-
try. Transferred NK cells could be detected in the spleen (Figures
3C and 3D), with a localization similar to that seen for endoge-
nous NK cells (Figure 1D). By flow cytometry, the number of
recovered NK cells was similar at 18 hr and 7 days after transfer
(Figure 3E). These data suggest that the differences in suppres-
sive function of NK cells from naive and infected mice were not
due to differential survival or homing. Using this approach, we
also confirmed that NK cells directly home into hepatic granulo-
Figure 2. Splenic and Hepatic IL-10+ NK Cells Expand in Number
during Experimental Visceral Leishmaniasis
Total number (± SD) of splenic (A) and hepatic (B) CD3CD49b+ NK cells in
naive and 28 day-infected BALB/c mice (n = 4). Spleen (C) and liver (D) cells
were prepared from naive BALB/c mice and BALB/c mice infected for 7
days, 14 days, or 28 days with L. donovani. CD4+CD3+ cells, CD8+CD3+
T cells, NKp46+CD49b+ cells, and all residual cells (including DCs, macro-
phages, and stromal cells) were sorted to > 99% purity and then examined
for IL-10 mRNA accumulation by RT-PCR. Data represent mRNA samples
from sorted cells isolated from pools of n = 5 spleens and are shown as n-
fold difference over naive. Data from one of two independent experiments is
shown.
298 Immunity 29, 295–305, August 15, 2008 ª2008 Elsevier Inc.mas (Figures 3F and 3G). As with endogenous NK cells, trans-
ferred NK cells were observed in most, but not all, granulomas
(Figure 3F).
As 50% of NK cells in infected BALB/c mice expressed
CD11c (Figure S2), we wished to determine whether this inhibi-
tory functionmight be attributable to this emergent CD11clo pop-
ulation of NK cells. However, as shown in Figures 3H and 3I,
sorted CD11 and CD11clo subsets of CD49b+ NK cells equally
inhibited host resistance (by 3.05 ± 0.5-fold and 3.41 ± 0.56-fold
in the spleen and 2.59 ± 0.25-fold and 3.22 ± 0.24-fold in the liver
for CD11c and CD11lo NK cells, respectively; n = 5 and p < 0.01
in all cases versus no transfer or transfer of naive NK cells). In
spite of this inhibitory activity, both CD11 and CD11clo subsets
also exhibited enhanced cytotoxic effector function compared to
NK cells from naive mice (Figure S5). By these assays, diverse
functions of NK cells did not, therefore, segregate on the basis
of CD11c expression.
Il10+/+ but Not Il10/ NK Cells Can Suppress Host
Resistance to L. donovani
Although providing the first functional evidence that NK cells can
suppress host resistance, these experiments did not directly
address whether this was mediated via IL-10. To address this
question, we developed a mixed-chimera approach, which
allowed both progression of L. donovani infection and also the
activation of both IL-10-sufficient and IL-10-deficient NK cells
within the same infected host. We first generated mixed chi-
meras on the BALB background, transferring bone marrow
derived from Thy1.2+ BALB.Il10/ and Thy1.1+ BALB.Il10+/+
into Thy1.1+ BALB.Il10+/+ recipients. However, as a result of
limited expression of Thy1 on NK cells (Dunn and North, 1991;
Rahal et al., 1991), it was not possible to recover sufficient
Il10/ and Il10+/+ NK cells for subsequent adoptive transfer.
We thereforeusedCD45.1+B6.Il10+/+ andCD45.2+B10.Il10/
mice as an alternate genetic system. As in BALB/c mice, the
number of CD3NKp46+ NK cells in the spleen of infected B6
mice also increased during infection (from 2.7 ± 0.2 to 3.9 ±
1.53 106 per spleen), and theseNK cells had increased accumu-
lation of IL-10 mRNA compared to naive mice (8.4 ± 0.3-fold).
However, the magnitude of the NK response in B6mice, as mea-
sured by both these parameters, was clearly more muted than in
BALB/c mice (Figures 1 and 2). Nevertheless, we generated
(CD45.1+ B6.Il10+/+ + CD45.2+ B10.Il10/) / CD45.1
B6.Il10+/+ irradiation chimeras and after 8 weeks of reconstitu-
tion, these mice were infected with L. donovani (Figure 4A). At
day 28 p.i., IL-10-sufficient (CD49b+CD45.1+) and IL-10-deficient
(CD49b+ CD45.2+) NK cells (Figure 4B) were present in similar ra-
tios. Sorted (>98%purity) NK cells were then transferred into day
21-infected CD45.1+ B6.Il10+/+ recipient mice. Whereas IL-10-
sufficent NK cells inhibited splenic (Figure 4C) and hepatic
(Figure 4D) resistance to L. donovani, the transfer of Il10/ NK
cells had no effect compared to mice receiving no cell transfer.
In two independent experiments, Il10+/+ NK cells increased par-
asite burden by 2.58 ± 0.41-fold and 2.2 ± 0.29-fold in spleen
and liver, respectively (n = 10, p < 0.01), whereas Il10/ NK cells
increased parasite burden by only 1.3 ± 0.22-fold and 1.12 ±
0.01-fold in spleen and liver, respectively (n = 10, ns). Even given
the caveat that the NK cell response in B6 mice was less dra-
matic than that seen in BALB/c mice, these data provide a formal
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(A and B) NK cells isolated from naive BALB/c mice (N-NK) or day 21-infected BALB/c mice (I-NK) were flow sorted and transferred (106 i.v.) into day 21-infected
BALB/c recipients. Control mice received no transfer (NT). (A) Splenic and (B) hepatic parasite burdens were determined 7 days after transfer. Symbols represent
individual mice and bar represents mean value. Data from one of four independent experiments are shown.
(C) Immunohistology of day 21-infected BALB/c spleen showing distribution of transferred CFSE+NK cells (white). Sections were counterstained with DAPI (blue).
(D) Frequency of CFSE+ NK cells distributed to the red pulp, white pulp, or marginal zone were enumerated 24 hr after transfer.
(E) CFSE-labeled NK cells (23 106 i.v.) purified from naive and day 21-infected BALB/c mice were transferred into day 21-infected recipient mice; then, 18 hr and
7 days after transfer, donor NK cells were enumerated in the spleen (mean ± SD of n = 4 mice).
(F and G) Distribution of CFSE-labeled NK cells in liver granulomas caused by L. donovani with (F) low-magnification and (G) high-magnification images.
(H and I) NK cells from naive mice (N-NK) and from day 21-infected BALB/c mice (I-NK) sorted into their CD11c and CD11clo subsets were transferred into day
21-infected recipients, and 7 days later (H) splenic and (I) hepatic parasite burden was determined.demonstration that the ability to produce IL-10 is essential for NK
cells to suppress host resistance in vivo.
Acquisition of an IL-10-Secreting Phenotype Requires
Sustained NK Cell Activation
NK cells are activated within the first few days of Leishmania
infection to secrete IFN-g (Martin-Fontecha et al., 2004;
Schleicher et al., 2007), but their ability to produce IL-10 early af-
ter infection has not been assessed. For further exploration of the
kinetics of the IL-10 response, CD49b+ NK cells were sorted
from naive BALB/c mice and BALB/c mice infected for either24 hr or 21 days with L. donovani. Unexpectedly, RT-PCR anal-
ysis indicated similar accumulation of IL-10 mRNA at both time
points (Figure 5A). We then examined the capacity of NK cells
isolated from 24 hr- and day 21-infected mice to inhibit host re-
sistance. In contrast to NK cells isolated at day 21 p.i, NK cells
isolated at 24 hr p.i. had no suppressive effect (Figures 5B and
5C). Thus, from three independent experiments (n = 10–14), NK
cells from day 21- and from 24 hr-infected mice increased para-
site burden by 2.47 ± 0.17-fold versus 1.01 ± 0.13-fold in the
spleen (p < 0.001) and 2.16 ± 0.16-fold versus 1.05 ± 0.15-fold
in the liver (p < 0.001). These data suggested that IL-10 mRNA
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Regulation of Host Immunity by NK CellsFigure 4. Adoptive Transfer of NK Cells Demonstrates Their IL-10-Dependent Capacity to Inhibit Host Resistance
(A) Schematic showing design for experiment with mixed chimeras.
(B) The frequencies of CD49b+ IL-10-sufficient (CD45.1) and IL-10-deficient (CD45.2) splenic NK cells in infected chimeras was determined by flow cytometry.
Plots are gated on CD49b+CD3 cells.
(C and D) Sorted cells from day 28-infected chimeric mice were transferred into day 21-infected B6 mice, and 7 days later (C) splenic and (D) hepatic parasite
burden was determined. Data from one of two independent experiments is shown. Symbols represent individual mice and the bar represents mean value.accumulation could not reliably indicate the inhibitory function
of NK cells in this assay. We therefore determined whether
both populations of NK cells were similarly capable of secreting
IL-10, as well as IFN-g (Figures 5D–5F). NK cells were cultured
in vitro in the presence or absence of rIL-12, because this cyto-
kine has also been shown to induce both IL-10 and IFN-g from
NK cells (Mehrotra et al., 1998). NK cells from naive mice were
readily activated in a dose-dependent manner by rIL-12 to pro-
duce IFN-g (Figure 5D). In contrast, only low amounts of IL-10
(60–120 pg/ml) were produced at the highest dose of rIL-12
tested (5 ng/ml). NK cells from day 21-infected mice produced
high amounts of IL-10 (500–1200 pg/ml), with even low doses
of rIL-12 tested (Figure 5F). IL-10 secretion did not affect the pro-
duction of IFN-g, which was produced in similar concentrations
and with similar kinetics to that found in cultures of NK cells from
naive mice. In contrast, NK cells isolated frommice 24 hr p.i. had
an enhanced IFN-g response, yet produced minimal quantities
of IL-10, requiring high doses of rIL-12 to elicit a response (Fig-
ure 5E). These data suggest that NK cells acquired the capacity
to secrete high amounts of IL-10 as infection progressed.
Posttranscriptional regulation of IL-10 gene expression has
been shown to control IL-10 secretion in a variety of cell types,
including macrophages and keratinocytes (Powell et al., 2000).
To explore whether this mechanism might account for the
disparity between IL-10 mRNA accumulation and IL-10 protein
secretion noted above, we used actinomycin D to block tran-
scription and examine IL-10 mRNA stability. In NK cells isolated
300 Immunity 29, 295–305, August 15, 2008 ª2008 Elsevier Inc.at 24 hr p.i., IL-10 mRNA decayed by almost 95% within 60 min
of addition of actinomycin D (Figure 5G), similar to a recent report
using cultured NK cells (Grant et al., 2008). In contrast, NK cells
isolated at day 21 p.i. had retained 60% of their initial IL-10
mRNA over a similar time period, representing an approximate
doubling in relative mRNA half-life (75 min versus 30 min in
NK cells from day 21- versus 24 hr-infected mice, respectively).
These data suggest that altered mRNA stability contributes to
the increased capacity of NK cells from day 21-infected mice
to secrete IL-10. Together, our data indicate that over time, NK
cells acquire the capacity to suppress hepatic resistance to
L. donovani by a mechanism that involves posttranscriptional
regulation of IL-10 gene expression, leading to elevated IL-10
protein production.
DISCUSSION
NKcells play a vital role in early pathogen containment and by vir-
tue of their capacity to produce IFN-g, they are widely regarded
as beneficial for host protection against intracellular pathogens.
In this report, we demonstrate that NK cells have the capacity
to act in the opposing manner, inhibiting host resistance to an
intracellular pathogen through their production of IL-10.
Reports implicating NK cells as negative regulators of immu-
nity are infrequent. Studies in IFN-g-deficient mice have sug-
gested that pulmonary NK cells contribute to the immunosup-
pressive environment in the lung after mycoplasma infection,
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Regulation of Host Immunity by NK CellsFigure 5. Posttranscriptional Regulation of Il10 Gene Expression and Increased IL-10 Secretion by NK Cells from L. donovani-Infected Mice
(A) mRNA accumulation was determined in NK cells isolated from naive mice and mice infected for 24 hr or 21 days with L. donovani. Data are derived from four
experiments (mean + SD), with mRNA obtained from NK cells pooled from 3–5 mice per experiment.
(B and C) NK cells from naive BALB/cmice (N-NK) and BALB/cmice infected for 24 hr or 21 days were transferred into day 21-infected BALB/c recipients, and (B)
splenic and (C) hepatic parasite burden was determined 7 days later. Data represent one of three independent experiments.
(D–F) CD49b+ NK cells were isolated from (D) naive BALB/c mice and BALB/c mice infected for (E) 24 hr or (F) 21 days with L. donovani and stimulated in vitro with
increasing doses of rIL-12 (0.05–5 ng/ml) or cultured in medium alone. Supernatants were collected each day for 4 days, and IL-10 (left panels) and IFN-g (right
panels) was determined by ELISA.
(G) NK cells from mice infected for 24 hr and 21 days were cultured in the presence of actinomycin D. At indicated times, IL-10 mRNA accumulation was deter-
mined. Data are expressed as percentage of remaining IL-10 mRNA relative to mRNA levels at time 0 (168 versus 163 molecules of IL-10 mRNA per 1000
molecules HPRT in 24 hr and day 21 samples, respectively). Data represent one of two independent experiments.and depletion of NK cells in IFN-g-deficient animals prior to
infection reduced the amount of IL-10 in BAL fluid (Woolard
et al., 2005). NK cells can inhibit CD4+ T cell IFN-g production
after murine cytomegalovirus infection (Su et al., 2001) and
have been described to inhibit autoimmunity (Baxter and Smyth,
2002; Flodstrom et al., 2002; Horwitz et al., 1997), with a correla-
tion between NK cell number and/or activity and periods of dis-
ease progression or remission being observed in multiple sclero-
sis and systemic lupus erythematosus (reviewed in (French and
Yokoyama, 2004). Additionally, prior depletion of NK cells aggra-
vates peptide-induced experimental allergic encephalomyelitis
(Zhang et al., 1997). Uterine NK cells at the fetal-maternal inter-
face are also thought to be essential at mediating tolerance to the
fetus (Moffett-King, 2002). Nevertheless, NK cells are almostuniversally regarded as promoting antimicrobial immunity. Our
finding that NK cells can inhibit host protection by production
of IL-10 now dispels the notion that NK cells always operate to
facilitate pathogen clearance.
IL-10 is well known as a critical regulator of immunity to Leish-
mania infection. IL-10/mice are highly resistant to L. donovani
infection (Murphy et al., 2001; Murray et al., 2002), and IL-10 is
essential for L. major persistence (Belkaid et al., 2002). Three
sources of IL-10 have been examined in great detail. Miles et al.
(2005) have highlighted the capacity of immune complexes to in-
duce IL-10 production from macrophages, and, subsequently,
a number of studies have indirectly shown a role for Ig in the es-
tablishment and maintenance of disease (Woelbing et al., 2006).
Belkaid et al. (2002) established a critical role for IL-10 producing
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act as a rheostat for the emerging CD4+ Th1 response (Belkaid
et al., 2002) and are vital for long-termmemory to reinfection (Bel-
kaid et al., 2002). Finally, CD25Foxp3 IL-10-producing CD4+
T cells expand during both L. donovani (Stager et al., 2006) and
L. major Seidman infection (Anderson et al., 2007). IL-10-pro-
ducing CD4+ T cells appear in greater numbers after day 21 of
L. donovani infection in BALB/c mice, a process regulated by
IL-6 produced by DCs (Stager et al., 2006). CD25Foxp3
CD4+ T cells have also been identified as a source of IL-10 in hu-
mans infected with L. donovani (Nylen et al., 2007).
Here, we demonstrate that NK cells isolated from L. donovani-
infected mice also produce IL-10 and confirm their ability to
regulate disease outcome in vivo. Our data indicate that the
well-defined early role for NK cells in enhancing Th1 differentia-
tion (Cerwenka and Lanier, 2001) is not the full extent of NK cell
function, and other immunoregulatory functions are acquired as
infection progresses. To date, our analysis of mice after NK cell
transfer has not revealed any significant alterations in the num-
ber of CD4+ or CD8+ T cells nor in the number or activation status
of themajor cDC subsets (data not shown). The ability to observe
transferred NK cells with two-photon intravital microscopy (L.B.,
A.M., and P.M.K., unpublished data) and the availability of mice
with cell-specific deficiency of IL-10R expression (R. Jack and
W. Muller, unpublished data; Aidinis et al., 2008) should help elu-
cidate their mechanism of action.
Although Nylen et al. (2007) did not identify NK cells as a major
source of IL-10 mRNA in human disease, NK cells account for
only 3% of cells in splenic aspirate, and IL-10 secretion was
not directly examined. Furthermore, the role of NK cells may
well become overshadowed by that of CD4+ T cells as disease
progresses, as indeed is suggested by our data. Given that the
presence of granulomatous inflammation has been associated
with subclinical infection with L. donovani and that in the mouse
model of VL, disease is less progressive than in humans (Kaye
et al., 2004), our data demonstrating the modulation of parasite
burden by NK cells suggest that IL-10-producing NK cells might
have a more dominant role at early stages of human VL, perhaps
contributing to the immunoregulatory balance that governs the
transition from subclinical infection to clinical disease. Neverthe-
less, NK cell numbers do increase during fatal experimental vis-
ceral leishmaniasis in the hamster, a model often regarded as
better reflecting end-stage human disease (Sartori et al., 1999).
Our data demonstrate that the capacity of NK cells to produce
IL-10 protein is acquired over the course of infection, whereas
the capacity to produce IFN-g remains largely unaltered. The
precise molecular mechanism(s) involved remain to be defined,
though our data point to enhanced IL-10mRNAstability as a con-
tributing factor. Although posttranscriptional regulation of cyto-
kine genes in NK cells has not been described, a precedent for
the control of IL-10 secretion by such a mechanism is found in
macrophages, where IL-10 mRNA stability has been shown to
be associated with regulatory elements in the 30 UTR (Powell
et al., 2000). Further studies will be required to determine
whether analogous mechanisms exist in murine NK cells. Stud-
ies carried out by Brady et al. (2004) demonstrated that stimulat-
ing NK cells with IL-2 and IL-21 can induce IL-10 production. We
show here that IL-12 can induce NK cells from infected mice to
secrete IL-10, and human NK cells respond to IL-2 and IL-12
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studies indicate that in cultured murine NK cells, these cytokines
act synergistically to drive Stat4-dependent but T-bet-indepen-
dent induction of IL-10 mRNA (Grant et al., 2008). Thus, it is
tempting to speculate that IL-2 and IL-12 may also play a role
in the development and/or maintenance of IL-10-producing NK
cells during experimental leishmaniasis. In support of such an
association, we have previously shown that the frequency of
IL-12p40+ cells in hepatic granulomas increases significantly be-
tween day 14 and day 28 p.i. (Engwerda et al., 1998), mirroring
the kinetics of emergence of IL-10-producing NK cells described
here. IL-2 has also been linked to the generation of IL-10 during
L. donovani infection (Bodas et al., 2006). Whether these cyto-
kines, or other environmental factors, are ultimately responsible
for modulating NK cell function remains to be established,
however.
Finally, our data suggest striking, if not mechanistic, parallels
in the functional differentiation of NK cells and CD4+ Th1 cells.
Recent studies (Jankovic et al., 2007) have identified conven-
tional IFN-g-producing Th1 cells as a major source of IL-10
after Toxoplasma gondii infection, proposing that expression of
IL-10 helps to suppress APC function as a regulatory mecha-
nism to limit immunopathology. Our data suggest that NK cells,
under the influence of an evolving inflammatory response, like-
wise further differentiate from a population characterized by
cytolytic effector activity and IFN-g production, into one that
also has the ability to secrete IL-10. Identifying the factors re-
sponsible for promoting this switch in cytokine profile may open
new avenues for therapeutic regulation of NK cell activity in a
variety of chronic infectious and noninfectious inflammatory
states.
EXPERIMENTAL PROCEDURES
Mice and Infection
BALB/c and C57BL6 mice were obtained from Charles River (UK), B10.Il10/
mice were originally developed by DNAX and were obtained from A. Sher
(NIAID, NIH), and BALB.Thy1.1 and BALB.Il10/ (Thy1.2) and hCD2-GFP
(de Boer et al., 2003) mice were the kind gift of J. Langhorne, A. O’Garra,
and D. Kioussis, respectively (NIMR, London). Mice were housed under spe-
cific pathogen-free conditions and used at 6–8 weeks of age. The Ethiopian
strain of Leishmania donovani (LV9) wasmaintained by serial passage in Syrian
hamsters. Amastigotes were isolated from infected spleens, as previously de-
scribed (Stager et al., 2000), and mice were infected with 2 3 107 L. donovani
amastigotes intravenously (i.v.) via the tail vein in 200 ml of RPMI 1640 (GIBCO,
Paisley, UK). Mice were sacrificed by cervical dislocation, and parasite bur-
dens in the liver and the spleen were determined fromGiemsa-stained impres-
sion smears (Engwerda et al., 1998). Parasite burden was expressed as Leish-
man-Donovan units (LDUs; i.e., the number of parasites per 1000 host cell
nuclei 3 organ weight) (Smelt et al., 1997). All experiments were approved
by the London School of Hygiene and Tropical Medicine (LSHTM) and Univer-
sity of York Animal Procedures and Ethics Committee and performed under
UK Home Office license.
For the generation of chimeras, donor mice were irradiated twice with 1100
rads on a split-dose regimen (550 rad on day 1 and day 2) and then were
reconstituted i.v. via the tail vein on day 2 with 2 3 106 T cell-depleted bone
marrow cells per mouse, comprising a 1:1 ratio of Il10+/+ and Il10 / cells
(see text for details). At 6–8 weeks after reconstitution, mice were examined
for chimerism by flow cytometry and infected as described above. For adop-
tive transfer, sorted splenic NK cell subsets from either naive or infected mice
were injected (13 106/mouse) i.v. into day 21-infected mice, and 1 week later
splenic and hepatic parasite loads were determined.
Immunity
Regulation of Host Immunity by NK CellsSplenic DC and NK Enrichment
Splenic NK cells from naive and infected mice were enriched by digesting the
spleens in RPMI supplemented with 0.1 mg/ml collagenase for 25 min at room
temperature (RT). B220+, CD19+, CD33+, and highly phagocytic cells were
separated with magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach,
Germany) and aMidiMACS separation column (Miltenyi Biotec). CD3CD49b+
NK cells were then purified with either a FACS Vantage (BD Biosciences,
Mountain View, CA) or a MoFlo (Dakocytomation) cell sorter. Sort gates are
described in the Results. Sorted cells exceeded > 98% purity.
Flow Cytometry
For flow cytometry, cells were incubated with 10 mg/ml 2.4G2 anti-FcRgII/III
mAb (ATCC, Rockville, MD) followed by staining with directly conjugated
monoclonal antibodies. Cells were stained with fluorescein isothiocyanate
(FITC)-conjugatedMHCII (2G9) and CD3 (145-2C11) antibodies; phycoerythrin
(PE)-conjugated CD45RB (16A), CD44 (IM7), Ly49b (DX5), NK 1.1 (PK136), and
Gr-1 (RB6-8C5) antibodies; biotinylated CD11c (HL3), MHC-II (2G9), CD4
(RM4-5), CD8 (53-6.7), CD80 (16.10A1), CD86 (GL1), CD19 (1D3), B220/
CD45R (RA3-6B2), and CD3e (145-2C11) antibodies; and APC-conjugated
CD11c (clone HL3) antibody (all from BD PharMingen, San Diego, CA). Biotiny-
lated antibodies were visualized with PerCP-streptavidin (BD PharMingen).
NKp46 expression was detected by use of a polyclonal antibody against
mouse NKp46 (R&D systems). Secondary staining was carried out with a
donkey anti-goat IgG alexa 488 antibody (Invitrogen). Some samples were
also stained with rabbit anti-ASGM1 (Cedarlane, Ontario, Canada) followed
by anti-rabbit alexa 647 (molecular probes). Minimal background staining
was observed with appropriate control FITC-conjugated, PE-conjugated,
biotinylated, and APC antibodies. All staining was performed on ice in phos-
phate-buffered saline (PBS) containing 2% FCS and 5 mM EDTA for 30 min.
Flow-cytometric analysis was performedwith a FACSCalibur (BDBiosciences,
Mountain View, CA) or a Cyan (Dakocytomation). Fifty thousand cells were
acquired and analyzed with either CellQuest (BD Biosciences) or Summit
(Dakocytomation) software. Samples were spiked with a known concentration
of microbeads (Polysciences) prior to acquisition in order to obtain absolute
numbers of cells.
In Vivo Depletion of ASGM1+ Cells
BALB/c mice were injected with 20 ml of rabbit polyclonal anti-ASGM1 (Cedar-
lane) or control polyclonal normal rabbit IgG (Sigma) in a total volume of 200 ml/
mouse 24 hr prior to infection and days 2, 4, and 6 p.i. Liver LDUs were
determined at day 28 after infection.
Cytotoxicity Assay
YAC-1 cells (103/well) were used as targets for NK cell-mediated lysis. In brief,
NK cell subsets isolated from naive and day 28-infected animals were seeded
in 96-well round-bottom plates at different E/T ratios and incubated at 37C for
4 hr. Each test sample was plated in triplicate. Cytotoxicity was measured with
the LIVE/DEAD Viability/Cytotoxity kit (Invitrogen) according tomanufacturer’s
instructions and published protocols (Papadopoulos et al., 1994).
Real-Time RT-PCR
RNAwas isolated from sorted cell subsets with an RNeasy kit, according to the
manufacturer’s instructions (QIAGEN). RNA was reverse transcribed into
cDNA with the first-strand cDNA synthesis kit according to the manufacturer’s
instructions (Invitrogen). Oligonuclotides (50–30) used for the specific amplifica-
tion of Il10 andHprtwere as described in (Ato et al., 2002). The real-time quan-
titative PCR was performed with the SYBR Green PCR kit in an ABI PRISM
7000 Sequence Detection System (Applied Biosystems) according to manu-
facturer’s instructions. Accumulation of Il10 was normalized to Hprt and
expressed as either absolute copy number (target molecules/1000 Hprtmole-
cules) or relative expression via the change in cycle threshold (DDCT) analysis
method (relative expression in infected versus naive mice).
Immunofluorescence
For immunofluorescence, cytospun cells were fixed in 4% paraformaldehyde
for 30 min at RT. After fixing, samples were quenched with 50 mM NH4Cl in
PBS for 30 min at RT and then blocked and permeabilized by incubation
with 1.5% v/v normal goat serum in 0.1% v/v saponin in PBS for 45 min atRT. Samples were incubated with biotin-conjugated rat anti-MHC-II (clone
2G9, BD PharMingen) and hamster anti-CD11c (clone N418, Serotec) diluted
in 0.1% v/v saponin in PBS and incubated for 45min at RT. After washing, spe-
cific staining was detected by Alexa 488-conjugated streptavidin and Alexa
546-conjugated goat-anti hamster IgG (Invitrogen). Slides were washed three
times with 0.1% v/v saponin in PBS, and then coverslips were mounted in
Prolong Gold (Invitrogen) and visualized with a 633 (NA 1.4) Plan-Apochromat
oil-immersion objective with a Zeiss Axioplan LSM 510 confocal microscope.
Confocal Microscopy
Confocal was performed on 8-mM-thick serial frozen sections. Sections were
fixed with ice-cold acetone before staining with anti-CD3 PE, anti-F4/80 biotin,
and goat anti-mouse NKp46 followed by secondary donkey anti-goat IgG
alexa 488 (molecular probes) and streptavidin 546. DAPI was used as a nuclear
counterstain. Slides were analyzed by confocal microscopy (Zeiss LSM 510).
mRNA Stability Determination
Purified NK cells isolated from infected BALB/c mice at 24 hr and day 21 p.i.
were incubated in the presence of actinomycin D (5 mg/ml). The cells were
collected for RNA extraction at 60 min intervals for 3 h after the addition of
actinomycin D, and data are plotted as percentage of Il10 mRNA remaining
relative to that determined at the addition of actinomycin D.
ELISA
Purified CD3CD49b+ NK cells were cultured (1 3 105 cells / well) in various
doses of IL-12. Supernatants were harvested at 24 hr intervals for 4 days.
IL-10 and IFN-g levels in supernatants were assayed with a sandwich ELISA
kit (BioSource) according to the manufacturer’s instruction.
Statistics
Statistical analysis was performed with a paired Student’s t test or a Mann
Whitney U test, as appropriate. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
SUPPLEMENTAL DATA
Supplemental Data include five figures and can be found with this article online
at http://www.immunity.com/cgi/content/full/29/2/295/DC1/.
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